Table 1.
The characteristics of the 29 included studies.
Fig 1.
Forest plot of the effect of tranexamic acid on hematoma growth (A), mRS (B), mRS≤2 (C), and mortality (D) in patients with ICH.
Fig 2.
Forest plot of the effect of tranexamic acid on GOS 3–5 (A), Mortality (B), DVT (C), IS or TIA (D), and Rebleeding (E) in patients with SAH.
Fig 3.
Forest plot of the effect of tranexamic acid on Hematoma growth (A), Mortality (B), PE (C), IS or TIA (D), and Seizures (E) in patients with SAH.